Please login to the form below

Not currently logged in
Email:
Password:

OSE Immunotherapeutics

This page shows the latest OSE Immunotherapeutics news and features for those working in and with pharma, biotech and healthcare.

China’s Innovent to start US trials of anti-CD47 cancer drug

China’s Innovent to start US trials of anti-CD47 cancer drug

And earlier this year Boehringer Ingelheim licensed a drug from French biotech OSE Immunotherapeutics that targets SIRP-alpha – which binds to CD47 – in a 1.1bn deal.

Latest news

  • Boehringer bolts on another immuno-oncology company Boehringer bolts on another immuno-oncology company

    ViraTherapeutics is just one a of a series of investments Boehringer has made in immuno-oncology, coming after a 1.1bn deal to license a checkpoint inhibitor from French biotech OSE ... Immunotherapeutics and earlier alliances with Siamab, AbeXXa

  • Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal

    Boehringer Ingelheim has licensed a new checkpoint inhibitor from French biotech OSE Immunotherapeutics in a deal that could be worth more than 1.1bn (around $1.4bn). ... The deal focuses around OSE-172, an anti-SIRP-alpha antibody with potential in

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Iris Pauporté joins OSE Immunotherapeutics Iris Pauporté joins OSE Immunotherapeutics

    Iris Pauporté joins OSE Immunotherapeutics. She becomes clinical project director at the French biotech. ... Alain Chatelin, medical director at OSE Immunotherapeutics, said: “ We are very pleased to have Iris join our team. “

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics